“…Embryonic stem cells (ESCs) (Khan et al, 2015), IPSCs , human bone marrow mesenchymal stem cells (hBMSCs) (Xu et al, 2014), human umbilical cord MSCs (hUMSCs) (Zhang et al, 2015a), placenta MSCs (Tooi et al, 2016), hESCs-derived c-Myc-immortalized MSCs (Lai et al, 2016), IPSCs-derived MSCs (Zhang et al, 2015b), GATA-4 overexpressing MSCs (Yu et al, 2015), hematopoietic progenitor cells (Sahoo et al, 2011), human endothelial progenitor cells , human cardiac progenitor cells (Barile et al, 2014), cardiosphere-derived cells, a source of multipotent and progenitor cells (Lang et al, 2016), and differentiating neural progenitor cells (Takeda and Xu, 2015) are the stem cells which have been previously evaluated to this end. Embryonic stem cells (ESCs) (Khan et al, 2015), IPSCs , human bone marrow mesenchymal stem cells (hBMSCs) (Xu et al, 2014), human umbilical cord MSCs (hUMSCs) (Zhang et al, 2015a), placenta MSCs (Tooi et al, 2016), hESCs-derived c-Myc-immortalized MSCs (Lai et al, 2016), IPSCs-derived MSCs (Zhang et al, 2015b), GATA-4 overexpressing MSCs (Yu et al, 2015), hematopoietic progenitor cells (Sahoo et al, 2011), human endothelial progenitor cells , human cardiac progenitor cells (Barile et al, 2014), cardiosphere-derived cells, a source of multipotent and progenitor cells (Lang et al, 2016), and differentiating neural progenitor cells (Takeda and Xu, 2015) are the stem cells which have been previously evaluated to this end.…”